Amy Sullivan
2022
In 2022, Amy Sullivan earned a total compensation of $635.2K as Chief Financial Officer at IO Biotech.
Compensation breakdown
| Non-Equity Incentive Plan | $29,049 |
|---|---|
| Option Awards | $512,911 |
| Salary | $89,658 |
| Other | $3,555 |
| Total | $635,173 |
Sullivan received $512.9K in option awards, accounting for 81% of the total pay in 2022.
Sullivan also received $29K in non-equity incentive plan, $89.7K in salary and $3.6K in other compensation.
Rankings
In 2022, Amy Sullivan's compensation ranked 3,958th out of 5,756 executives tracked by ExecPay. In other words, Sullivan earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,958 out of 5,756 | 31st |
Division Manufacturing | 2,240 out of 3,133 | 29th |
Major group Chemicals And Allied Products | 1,086 out of 1,419 | 24th |
Industry group Drugs | 1,019 out of 1,320 | 23rd |
Industry Pharmaceutical Preparations | 746 out of 966 | 23rd |
Source: SEC filing on April 26, 2023.
Sullivan's colleagues
We found two more compensation records of executives who worked with Amy Sullivan at IO Biotech in 2022.